As FBXO16 can modulate and negatively correlate with many cellular signaling pathways in ovarian cancer cells, we hypothesize that FBXO16 could also regulate the polyubiquitination and degradation of other substrates, which requires further investigation to clarify. The gene discussed is FBXO16; the disease is ovarian cancer.